Memphasys: Now this is rare – a biotech that reaches commercialisation 
Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Memphasys: Now this is rare – a biotech that reaches commercialisation Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device. See omnystudio.com/listener for privacy information.

Memphasys: Now this is rare – a biotech that reaches commercialisation 
Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device.See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Memphasys: Now this is rare – a biotech that reaches commercialisation

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Business

Investing

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Share Memphasys: Now this is rare – a biotech that reaches commercialisation

Sign up to save your podcasts

Memphasys: Now this is rare – a biotech that reaches commercialisation

Memphasys: Now this is rare – a biotech that reaches commercialisation

More shows like Bulls N' Bears with Matt Birney

AFL Trade Radio

NAB Morning Call

Equity Mates Investing Podcast

Australian Investors Podcast

Money of Mine

The Explorers Podcast with Barry FitzGerald

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

Market Updates

Footy Classified